USD 0.0
(-13.04%)
Year | Net Income | Net Income Growth |
---|---|---|
2024 | -156.15 Thousand USD | 59.53% |
2023 | -385.87 Thousand USD | 12.87% |
2022 | -442.89 Thousand USD | -5190.69% |
2021 | 8700.00 USD | 0.0% |
2020 | - USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q3 | -11.44 Thousand USD | 38.72% |
2024 Q4 | -101.91 Thousand USD | -790.19% |
2024 Q2 | -18.68 Thousand USD | 22.48% |
2024 Q1 | -24.1 Thousand USD | 56.82% |
2024 FY | -156.15 Thousand USD | 59.53% |
2023 Q2 | -8043.00 USD | 96.81% |
2023 FY | -385.87 Thousand USD | 12.87% |
2023 Q4 | -55.81 Thousand USD | 8.14% |
2023 Q3 | -60.76 Thousand USD | -655.53% |
2023 Q1 | -252.38 Thousand USD | -35.5% |
2022 FY | -442.89 Thousand USD | -5190.69% |
2022 Q1 | -90.7 Thousand USD | -1953.15% |
2022 Q3 | 3983.00 USD | 102.34% |
2022 Q2 | -169.99 Thousand USD | -87.41% |
2022 Q4 | -186.26 Thousand USD | -4776.48% |
2021 Q2 | -30.00 USD | 99.65% |
2021 FY | 8700.00 USD | 0.0% |
2021 Q4 | -4418.00 USD | -120.33% |
2021 Q3 | 21.72 Thousand USD | 72526.67% |
2021 Q1 | -8580.00 USD | 0.0% |
2020 FY | - USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
China Medicine Corporation | 1.71 Million USD | 109.091% |
Exlites Holdings International, Inc. | -90.49 Thousand USD | -72.558% |
Itonis, Inc. | -38.31 Thousand USD | -307.572% |
One Step Vending Corp. | -27.79 Thousand USD | -461.904% |
MediPal Holdings Corporation | 274.02 Million USD | 100.057% |
PD-Rx Pharmaceuticals, Inc. | -98.06 Thousand USD | -59.236% |
Pharmagen, Inc. | -6457.61 USD | -2318.124% |
Suzuken Co., Ltd. | 191.71 Billion USD | 100.0% |